Tempest Therapeutics (TPST) Share-based Compensation (2012 - 2018)
Tempest Therapeutics' Share-based Compensation came in at $347,000 for Q3 2018, down 24.4% from $459,000 a year earlier and down 34.5% from the prior quarter.
Powered by 
Analysis
Tempest Therapeutics (TPST) Share-based Compensation (2012 - 2018) Analysis & Trends
Over the trailing twelve months to Sep 30, 2018, Tempest Therapeutics reported Share-based Compensation of $1.78 million, down 75.9% year-over-year; for FY2017, it was $6.89 million, down 25.2% from FY2016.
- Share-based Compensation carries a five-year compound annual growth rate of 37.9% (FY2012 to FY2017).
- Going back by year, Share-based Compensation was $9.22 million in FY2016 (-52.3%), $19.34 million in FY2015 (+55.9%), $12.41 million in FY2014 (+143.6%) and $5.09 million in FY2013 (+268.6%).
- The Q3 2018 figure represents the lowest quarterly Share-based Compensation since Q3 2012.
- Year-over-year, Share-based Compensation has declined for five consecutive quarters, with an average decline of 43.2% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q1 2015 (growth of 634.4%), and the weakest in Q2 2018 (a decline of 88.4%).
- Business Quant data shows TPST's Share-based Compensation at $530,000 (Q2 2018), $382,000 (Q1 2018) and $516,000 (Q4 2017) in the three quarters before Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Tempest Therapeutics | 4.09 Mn | -26.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 347,000.00 |
| Jun 30, 2018 | 530,000.00 |
| Mar 31, 2018 | 382,000.00 |
| Dec 31, 2017 | 516,000.00 |
| Sep 30, 2017 | 459,000.00 |
| Jun 30, 2017 | 4.56 Mn |
| Mar 31, 2017 | 1.36 Mn |
| Dec 31, 2016 | 990,000.00 |
| Sep 30, 2016 | 2.51 Mn |
| Jun 30, 2016 | 2.17 Mn |
| Mar 31, 2016 | 3.55 Mn |
| Dec 31, 2015 | 4.92 Mn |
| Sep 30, 2015 | 3.70 Mn |
| Jun 30, 2015 | 4.35 Mn |
| Mar 31, 2015 | 6.37 Mn |
| Dec 31, 2014 | 6.37 Mn |
| Sep 30, 2014 | 2.95 Mn |
| Jun 30, 2014 | 2.22 Mn |
| Mar 31, 2014 | 867,000.00 |
| Dec 31, 2013 | 1.26 Mn |
API Access
Tempest Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TPST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TPST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TPST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();